First time available for research use

HER2 | ERBB2-antibody

Pertuzumab antibody from Perjeta®

NEW ! Available with Certificate of Analysis (CoA)

Therapeutic HER2 | ERBB2-antibody from the original Perjeta® commercial drug targeting the HER2-antigen, also referred to as Perjeta® or Pertuzumab antibody. Research-relevant quantities are available as licence-free consumable in aliquoted or diluted variant. Therapeutic monoclonal antibodies can be used from researchers in in vitro and in vivo experiments, biosimilar developers can order different batches at the same time.

NEW: This product is available with the original manufacturers Certificate of Analysis (CoA)!

Choose your antibody
ERBB2-antibody-pertuzumab
Easy Access

Easy Access

Easy to order as license-free research consumable
Multiple batches

Multiple batches

Up to 10 batches of original drugs for examining batch-to-batch variations
Reduce costs

Reduce costs

Up to 80% less compared to the original pharmaceutical price
Prompt delivery

Prompt delivery

Shipment within days worldwide according to GDP-standards
Documented origin

Documented origin

Information on batch, registration number, expiry date, GDP-compliant pedigree

What our clients say

Product Reference